Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Larder

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Virology|May 3, 2001
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapyL Bacheler, S Jeffrey, G Hanna, et al.
AIDS Research and Human Retroviruses|March 1, 1997
Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected personsS M Bruisten, P H Frissen, P Van Swieten, et al.
Virology|October 6, 2000
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAARTE Caride, R Brindeiro, K Hertogs, et al.
Virus Genes|November 29, 2001
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAARTE Caride, K Hertogs, B Larder, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'IvoireC Adjé, R Cheingsong, T H Roels, et al.
AIDS (London, England)|June 15, 2000
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnelS A Wegner, S K Brodine, J R Mascola, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasmaD W Haas, L A Clough, B W Johnson, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Virology|May 3, 2001
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapyL Bacheler, S Jeffrey, G Hanna, et al.
AIDS Research and Human Retroviruses|March 1, 1997
Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected personsS M Bruisten, P H Frissen, P Van Swieten, et al.
Virology|October 6, 2000
Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAARTE Caride, R Brindeiro, K Hertogs, et al.
Virus Genes|November 29, 2001
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAARTE Caride, K Hertogs, B Larder, et al.
The Journal of Infectious Diseases|June 3, 2000
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapyM Dybul, T W Chun, D J Ward, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'IvoireC Adjé, R Cheingsong, T H Roels, et al.
AIDS (London, England)|June 15, 2000
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnelS A Wegner, S K Brodine, J R Mascola, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasmaD W Haas, L A Clough, B W Johnson, et al.
Pageof 4